MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Community

Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.40 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade MGRX?

Rallies community data for MGRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

MGRX Key Metrics

Key financial metrics for MGRX
MetricValue
Price$0.40
Market Cap$6.87M
P/E Ratio-0.19
EPS$-2.17
Dividend Yield0.00%
52-Week High$7.66
52-Week Low$0.16
Volume69
Avg Volume0
Revenue (TTM)$456.02K
Net Income$-20.64M
Gross Margin54.91%

Latest MGRX News

Recent MGRX Insider Trades

  • JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
  • JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
  • JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.

MGRX Analyst Consensus

MGRX analyst coverage data. Average price target: $0.00.

Common questions about MGRX

How does the Rallies community trade MGRX?
Rallies community data for MGRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for MGRX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for MGRX when enough community data is available.
Is MGRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.
MGRX

MGRX